Activity of gepotidacin against molecularly characterized Klebsiella pneumoniae isolates from patients with urinary tract infections in Europe and adjacent regions (2019–2022)
Activity of gepotidacin against molecularly characterized Klebsiella pneumoniae isolates from patients with urinary tract infections in Europe and adjacent regions (2019–2022). Lead Author: Rodrigo Mendes at ECCMID, 27-30 April 2024, Barcelona, Spain
Poster #P2479
